Theodore Pincus to Evidence-Based Medicine
This is a "connection" page, showing publications Theodore Pincus has written about Evidence-Based Medicine.
Connection Strength
1.074
-
Shouldn't standard rheumatology clinical care be evidence-based rather than eminence-based, eloquence-based, or elegance-based? J Rheumatol. 2007 Jan; 34(1):1-4.
Score: 0.268
-
Evidence-based practice and practice-based evidence. Nat Clin Pract Rheumatol. 2006 Mar; 2(3):114-5.
Score: 0.253
-
Guidelines for monitoring of methotrexate therapy: "evidence-based medicine" outside of clinical trials. Arthritis Rheum. 2003 Oct; 48(10):2706-9.
Score: 0.214
-
Limitations of clinical trials in chronic diseases: is the efficacy of methotrexate (MTX) underestimated in polyarticular psoriatic arthritis on the basis of limitations of clinical trials more than on limitations of MTX, as was seen in rheumatoid arthritis? Clin Exp Rheumatol. 2015 Sep-Oct; 33(5 Suppl 93):S82-93.
Score: 0.123
-
Evidence that the strategy is more important than the agent to treat rheumatoid arthritis. Data from clinical trials of combinations of non-biologic DMARDs, with protocol-driven intensification of therapy for tight control or treat-to-target. Bull Hosp Jt Dis (2013). 2013; 71 Suppl 1:S33-40.
Score: 0.101
-
An evidence-based medical visit for patients with rheumatoid arthritis based on standard, quantitative scientific data from a patient MDHAQ and physician report. Bull NYU Hosp Jt Dis. 2012; 70(2):73-94.
Score: 0.095
-
The 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for rheumatoid arthritis: Phase 2 methodological report. Arthritis Rheum. 2010 Sep; 62(9):2582-91.
Score: 0.022